Sean A. Power, CPA — Chief Financial Officer at TG Therapeutics | Comparably
TG Therapeutics Claimed Company
TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI® (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features. read more
EMPLOYEE
PARTICIPANTS
22
TOTAL
RATINGS
396
HR or Marketing? Claim Your Free Employer Account
Sean A. Power, CPA — Chief Financial Officer at TG Therapeutics

Sean A. Power, CPA — Chief Financial Officer at TG Therapeutics

Executive Bio

Sean A. Power, CPA, has served as the Company’s Chief Financial Officer since December 2011. Mr. Power joined the Company from Keryx Biopharmaceuticals, Inc. (KERX), where he served as Corporate Controller from 2006 to 2011. During his tenure there, Mr. Power was involved in all capital raising and licensing transactions. He was also responsible for leading Keryx’s compliance with Securities and Exchange Commission rules and regulations. Prior to joining Keryx, he was with KPMG, LLP, independent certified public accountants, where he served as a senior associate. Mr. Power received a BBA in accounting from Siena College and is a member of the American Institute of Certified Public Accountants.

Executive Team Culture Ratings from TG Therapeutics Employees

TOP
50%
TG Therapeutics' Executive Team scores in the Top 50%
of similar sized companies on Comparably
Who ranks the Executive Team the highest?
Experience - 3 to 6 Years 77/100
Gender - Female 67/100
Ethnicity - Hispanic or Latino 64/100
Who ranks the Executive Team the lowest?
Experience - 1 to 3 Years 40/100
Gender - Male 42/100
Department - All Industries 46/100

TG Therapeutics' Executive Team at a Glance

Based on 20 ratings, TG Therapeutics' employees are less satisfied with their Executive Team and give them a “C+” or 69/100. On average, Women provided higher ratings for their Executive Team compared to Men.

TG Therapeutics' Executive Team ranks in the Top 40% of other companies in Burlington, NC and Top 50% of other companies on Comparably that also have 201-500 Employees.

×
Rate your company